EuroAPI

At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

News from this company

News

EuroAPI Secures €130-150 Million Animal Health Contract

23.05.2024 -

EuroAPI has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company.

News

2024 Guidance Suspended: API Production Paused in Brindisi, Italy

19.03.2024 -

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.

News

EuroAPI Collaborates with Contract Research Organization SpiroChem

26.01.2024 -

Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO)...

News

EuroAPI Completes Acquisition of BianoGMP

22.11.2023 -

EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.

News

EuroAPI Announces New Governance

26.10.2023 -

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane...

Chemistry & Life Sciences

Ensuring API Supply Capacities for Europe and Beyond

13.10.2022 -

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.

Contact

EuroAPI

15 rue Traversière
75012 Paris
France